News

Researchers from TU Delft have found a new method to efficiently make nano carriers loaded with radioactive salts for both medical imaging and treatment. Because the assembly of these nano carriers is incredibly simple, the innovation is very suitable for clinical research and treatments of cancer patients.

More and more greenhouses are being built worldwide due to their reliable environmental conditions; inside however, the amount of sunlight that plants can use for growth is limited. Physicist Sadiq van Overbeek from PHYSEE Technologies, a spin-off of the Radiation Science & Technology department of TU Delft at TU Delft Reactor Institute & Radiation Science and Technology, found a solution to this bottleneck: a special coating on the greenhouse that converts incoming light towards the part of the spectrum that plants use for photosynthesis. Van Overbeek: “First results show up to 10% more crops with this PAR+ coating.”

The Dutch Research Council (NWO) has awarded a Veni grant to researcher Robin de Kruijff of the Reactor Institute Delft (RID) for her research on a new type of radionuclide generator which, among other things, can obviate the global bottleneck in cancer research. The new generator will, moreover, be the first recyclable one of its kind. “I hope that my new type of generator will ultimately make diagnostic treatments much more accessible and less dependent on a handful of reactors”, says De Kruijff.

Recently an important project on fuels for future generation of reactors has been concluded. The aim of the INSPYRE project: investigation of fast reactor Mixed Oxide (MOX) fuel to support the development and qualification of the fuels for the future generation of reactors.

Currently, storage is the key issue holding back the energy transition. Professor Fokko Mulder and CEO Mattijs Slee from Battolyser Systems are within reach of the solution: the Battolyser is a battery and a hydrogen factory in one. The TU Delft spin-off is a textbook example of how to create impact from research.

The Reactor Institute Delft (RID) continuously invests in better measuring methods and techniques in order to facilitate pioneering research. We have accelerated this with the OYSTER (Optimised Yield - for Science, Technology & Education - of Radiation) programme.

MILabs, a TU Delft spin-off that develops ground breaking imaging devices, is acquired by Rigaku Corporation. Founded in 2006, MILabs provides pre-clinical imaging systems and equipment with higher efficiency and accuracy than conventional alternatives. MILabs has developed a unique system that enables high performance nuclear medicine imaging. The innovative technique contributes to the quest for new therapies and new insights into disease biology in research labs around the world.